<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><description>药渡以自有药物大数据为依托，对上市及临床在研药物、药物研究进展和重要药物市场商业动态作出信息整合分析，传递药物创新一手资讯</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 05 May 2021 10:08:06 +0800</pubDate><image><url>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</url><title>药渡 | wechat-feeds</title><link>http://MzA5MjEzODQ3NA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>【一病一图】子宫内膜癌的临床用药竞争格局(2021.4)</title><link>https://mp.weixin.qq.com/s/SEbf6PkNRx4kSQQhE8n6Mw</link><description></description><content:encoded><![CDATA[【一病一图】子宫内膜癌的临床用药竞争格局(2021.4)]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>厦门大学报道三阴性乳腺癌的一种潜在治疗策略：EGFR CAR-T联合CDK7-TKI</title><link>https://mp.weixin.qq.com/s/zQFo0i5n5KHunf6fChS0KA</link><description></description><content:encoded><![CDATA[厦门大学报道三阴性乳腺癌的一种潜在治疗策略：EGFR CAR-T联合CDK7-TKI]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>劳动最光荣 | 记录劳动瞬间，领取现金大奖</title><link>https://mp.weixin.qq.com/s/O9Ka6ROVpKcAXE36lSSsOg</link><description></description><content:encoded><![CDATA[劳动最光荣 | 记录劳动瞬间，领取现金大奖]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>【5月11日，线上直播】非小细胞肺癌影像学疗效评估及进展</title><link>https://mp.weixin.qq.com/s/BYWVdOpGHHca5w_VHdCT_A</link><description></description><content:encoded><![CDATA[【5月11日，线上直播】非小细胞肺癌影像学疗效评估及进展]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>好书推荐 |《新药化学全合成路线手册》</title><link>https://mp.weixin.qq.com/s/vjchq9bSXAf3yLZlqc7DAw</link><description></description><content:encoded><![CDATA[好书推荐 |《新药化学全合成路线手册》]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>有偿投稿 | 让你的知识创造更大的价值！</title><link>https://mp.weixin.qq.com/s/D30GkxCayjimJy8m7RU2ow</link><description></description><content:encoded><![CDATA[有偿投稿 | 让你的知识创造更大的价值！]]></content:encoded><pubDate>Tue, 04 May 2021 18:49:36 +0800</pubDate></item><item><title>【一图一药】从Dostarlimab看PD-1抗体的竞争格局</title><link>https://mp.weixin.qq.com/s/qWwYGIwZN7QwXdN-2nuosg</link><description></description><content:encoded><![CDATA[【一图一药】从Dostarlimab看PD-1抗体的竞争格局]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>Cell Rep：基于类器官的高通量RNA测序有助于寻找治疗结直肠癌的药物</title><link>https://mp.weixin.qq.com/s/ZoFFYIBdkRO7UWL-y9nWHQ</link><description></description><content:encoded><![CDATA[Cell Rep：基于类器官的高通量RNA测序有助于寻找治疗结直肠癌的药物]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>劳动最光荣 | 记录劳动瞬间，领取现金大奖</title><link>https://mp.weixin.qq.com/s/wAFHWI6RGa_xTKvnMpGslQ</link><description></description><content:encoded><![CDATA[劳动最光荣 | 记录劳动瞬间，领取现金大奖]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>【5月14日，线上直播】肝病新药研发的挑战和机遇</title><link>https://mp.weixin.qq.com/s/SiILjcHnZLXrSbEJNaCBgA</link><description></description><content:encoded><![CDATA[【5月14日，线上直播】肝病新药研发的挑战和机遇]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>好书推荐 |《药物结构优化设计策略和经验规则》</title><link>https://mp.weixin.qq.com/s/mOVxkfkCXLYSBlshPc9CMA</link><description></description><content:encoded><![CDATA[好书推荐 |《药物结构优化设计策略和经验规则》]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>有偿投稿 | 让你的知识创造更大的价值！</title><link>https://mp.weixin.qq.com/s/7C6RCBExVXGcen9AkAvb6g</link><description></description><content:encoded><![CDATA[有偿投稿 | 让你的知识创造更大的价值！]]></content:encoded><pubDate>Sun, 02 May 2021 18:58:54 +0800</pubDate></item><item><title>欢度五一！劳动你我最光荣！</title><link>https://mp.weixin.qq.com/s/8KY0wQpYi_S78EMTrzkcKg</link><description></description><content:encoded><![CDATA[欢度五一！劳动你我最光荣！]]></content:encoded><pubDate>Fri, 30 Apr 2021 17:48:41 +0800</pubDate></item><item><title>劳动最光荣 | 记录劳动瞬间，领取现金大奖</title><link>https://mp.weixin.qq.com/s/bPunpoXdHwfc0bAsWsHEHA</link><description></description><content:encoded><![CDATA[劳动最光荣 | 记录劳动瞬间，领取现金大奖]]></content:encoded><pubDate>Fri, 30 Apr 2021 17:48:41 +0800</pubDate></item><item><title>好书推荐|《创新药物研发经纬》——国内首部回顾和展望新药研发何去何从的专著</title><link>https://mp.weixin.qq.com/s/TSaXXRowssghviZrMDjqZA</link><description></description><content:encoded><![CDATA[好书推荐|《创新药物研发经纬》——国内首部回顾和展望新药研发何去何从的专著]]></content:encoded><pubDate>Fri, 30 Apr 2021 17:48:41 +0800</pubDate></item><item><title>法尼醇受体激动剂LJN452开发：构象限制策略应用实例</title><link>https://mp.weixin.qq.com/s/80t0iwUPK5sChfBq30yENQ</link><description></description><content:encoded><![CDATA[法尼醇受体激动剂LJN452开发：构象限制策略应用实例]]></content:encoded><pubDate>Thu, 29 Apr 2021 21:57:05 +0800</pubDate></item><item><title>精彩回顾 | 第七届中国医药研发及服务发展高峰论坛暨药物制剂前沿技术高峰论坛圆满落幕！</title><link>https://mp.weixin.qq.com/s/68UYZmaI1y0zQ2H7RmH9WA</link><description></description><content:encoded><![CDATA[精彩回顾 | 第七届中国医药研发及服务发展高峰论坛暨药物制剂前沿技术高峰论坛圆满落幕！]]></content:encoded><pubDate>Thu, 29 Apr 2021 21:57:05 +0800</pubDate></item><item><title>劳动最光荣 | 记录劳动瞬间，领取现金大奖</title><link>https://mp.weixin.qq.com/s/0xgs7pOEJywVCnck9vyBsA</link><description></description><content:encoded><![CDATA[劳动最光荣 | 记录劳动瞬间，领取现金大奖]]></content:encoded><pubDate>Thu, 29 Apr 2021 21:57:05 +0800</pubDate></item><item><title>糖尿病领域新王者：Tirzepatide</title><link>https://mp.weixin.qq.com/s/Q1gC-rcSHl4Oj8hBDOGWYQ</link><description></description><content:encoded><![CDATA[糖尿病领域新王者：Tirzepatide]]></content:encoded><pubDate>Thu, 29 Apr 2021 21:57:05 +0800</pubDate></item><item><title>【5月11日，线上直播】非小细胞肺癌影像学疗效评估及进展</title><link>https://mp.weixin.qq.com/s/K83gEvVPBo34lnAOB1Z6_g</link><description></description><content:encoded><![CDATA[【5月11日，线上直播】非小细胞肺癌影像学疗效评估及进展]]></content:encoded><pubDate>Thu, 29 Apr 2021 21:57:05 +0800</pubDate></item></channel></rss>